Dr. Reddy’s is launching doxercalciferol injection, in 4 mcg/2 mL multidose vials. The product is the generic of Sanofi-Aventis’ Hectorol (doxercalciferol) injection 4 mcg/2 mL (2 mcg/mL) ...

Lupin’s Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vial is the generic version of Genzyme’s Hectorol Injection. It is indicated for the treatment of secondary hyperparathyroidism in ...

Doxercalciferol 2mcg/mL; soln for IV inj. Give by IV bolus inj. Dialysis: initially 4mcg three times weekly after dialysis; titrate dose to maintain desired iPTH therapeutic range and serum calcium ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

PRINCETON, N.J. — Sandoz announced the launch of doxercalciferol injection vials, the first generic version of Genzyme’s Hectorol. Doxercalciferol injection vials are used for the treatment of ...

Dr. Reddy’s Laboratories (NYSE:RDY) has launched Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the therapeutic generic equivalent of Sanofi-Aventis' Hectorol (doxercalciferol) ...

Review the side-effects of Doxercalciferol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

WILMINGTON, Del., May 25 (Reuters) - Genzyme Corp has sued Sandoz Inc, accusing it of infringing the patent for its Hectorol drug which is approved for controlling hormone production in patients with ...

Dr Reddy’s Laboratories Ltd has launched Doxercalciferol injection in the US market. It is the therapeutic generic equivalent of Hectorol (doxercalciferol) injection approved by the US Food and Drug ...